Join to view full profile
740 Rose StLexington, KY 40536
Phone+1 859-323-5116
Fax+1 859-323-0702
Dr. Arnold is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
University of Virginia Medical CenterResidency, Internal Medicine, 1992 - 1995
University of Kentucky College of MedicineClass of 1992
Certifications & Licensure
KY State Medical License 1995 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
Clinical Trials
- Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
- Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
- Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
Publications & Presentations
PubMed
- Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).Aman Chauhan, Heidi L Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda
Clinical Cancer Research. 2026-10-15 - 1 citationsPDS0101 With Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.Jared Weiss, John Kaczmar, Ashish Chintakuntlawar, Francis P Worden, Ranee Mehra
JAMA Oncology. 2026-09-17 - Protocol of a randomized trial of "pathways," a hope intervention for people undergoing treatment for advanced lung cancer.Laurie E McLouth, Courtney Blair, Brent J Shelton, Jennifer S Cheavens, Vilma Bursac
Contemporary Clinical Trials. 2026-08-26
Press Mentions
For Those Facing Cancer Diagnosis, Clinical Trials Can Offer Outcomes Unavailable with Standard TherapiesOctober 30th, 2025- Dr. Susanne Arnold Honored with the William R. Willard Dean’s Recognition AwardOctober 17th, 2025
- Markey Hits 10,000 Patient Milestone in Cancer NetworkApril 22nd, 2025
Grant Support
- The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials NetworkOHIO STATE UNIVERSITY2014–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
